Despite the fact that TNF-induced apoptosis is not being shown in HepG2 cells, Chlorofusin may still be a great candidate for improving cancer therapy, with its binding to MDM2 and targeting the p53-MDM2 interaction. The gene discussed is TP53; the disease is cancer.